To hear about similar clinical trials, please enter your email below
Trial Title:
Brain Metastasis Development Mechanism in BCBM Patients
NCT ID:
NCT06330870
Condition:
Breast Cancer
Brain Metastasis
Conditions: Official terms:
Breast Neoplasms
Neoplasm Metastasis
Brain Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Screening
Masking:
None (Open Label)
Intervention:
Intervention type:
Procedure
Intervention name:
WGS/TME evaluation
Description:
WGS/TME evaluation with blood and brain metastasis tissue during brain metastasis
curative surgery
Arm group label:
WGS/TME evaluation
Summary:
This study is the experimental study for brain metastasis development mechanism in
patients with breast cancer with brain metastasis
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Breast cancer
- Brain metastasis curative surgery patient
Exclusion Criteria:
- Gamma Knife surgery patient
Gender:
Female
Minimum age:
N/A
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Ji-Yeon Kim
Address:
City:
Seoul
Zip:
06351
Country:
Korea, Republic of
Status:
Recruiting
Contact:
Last name:
Ji-Yeon Kim
Start date:
April 6, 2023
Completion date:
December 31, 2027
Lead sponsor:
Agency:
Samsung Medical Center
Agency class:
Other
Source:
Samsung Medical Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06330870
